| Targeting cancer stem cells to overcome chemoresistance T Nunes, D Hamdan, C Leboeuf, M El Bouchtaoui, G Gapihan, TT Nguyen, ... International journal of molecular sciences 19 (12), 4036, 2018 | 151 | 2018 |
| Genomics applied to the treatment of breast cancer D Hamdan, TT Nguyen, C Leboeuf, S Meles, A Janin, G Bousquet Oncotarget 10 (46), 4786, 2019 | 33 | 2019 |
| Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma G Bousquet, M El Bouchtaoui, C Leboeuf, M Battistella, M Varna, ... Oncotarget 6 (22), 19279, 2015 | 28 | 2015 |
| Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia D Hamdan, C Leboeuf, C Le Foll, G Bousquet, A Janin Cancer medicine 8 (5), 2005-2012, 2019 | 9 | 2019 |
| Genomics of breast cancer brain metastases: a meta-analysis and therapeutic implications TT Nguyen, D Hamdan, E Angeli, JP Feugeas, QV Le, F Pamoukdjian, ... Cancers 15 (6), 1728, 2023 | 6 | 2023 |
| A massive open online course to teach undergraduate medical students in oncology: keys of success D Hamdan, F Pamoukdjian, J Lehmann-Che, C de Bazelaire, L Vercellino, ... Heliyon 8 (11), 2022 | 5 | 2022 |
| Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer T Dao, G Gapihan, C Leboeuf, D Hamdan, JP Feugeas, H Boudabous, ... Oncotarget 11 (18), 1590, 2020 | 5 | 2020 |
| PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers J Paris, C Wilhelm, C Lebbé, M Elmallah, F Pamoukdjian, A Héraud, ... Clinical and Translational Medicine 14 (3), e1632, 2024 | 4 | 2024 |
| A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report D Hamdan, C Leboeuf, C Pereira, N Jourdan, L Verneuil, G Bousquet, ... BMC cancer 15, 1-6, 2015 | 4 | 2015 |
| Docetaxel, Carboplatin and Fluoro-Uracil (TCF) Induction Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Patients with Contraindication for Cisplatin … E Saada, FR Ferrand, M Fekih, D Hamdan, F Janot, S Temam, M Julieron, ... Annals of Oncology 23, ix340, 2012 | 2 | 2012 |
| Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis T Van Nguyen, D Hamdan, G Falgarone, KH Do, Q Van Le, ... Targeted Oncology, 1-13, 2024 | 1 | 2024 |
| A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases E Angeli, J Paris, O Le Tilly, C Desvignes, G Gapihan, D Boquet, ... Experimental Hematology & Oncology 13 (1), 41, 2024 | 1 | 2024 |
| Olaparib in the setting of radiotherapy-associated sarcoma: what can precision medicine offer for rare cancers? D Hamdan, L Marisa, C Tlemsani, E Angeli, M Soussan, N Derive, ... JCO Precision Oncology 7, e2200582, 2023 | 1 | 2023 |
| Expression of Angiopoietin-like 4 Fibrinogen-Like Domain (cANGPTL4) increases risk of brain metastases in women with breast cancer T Dao, G Gapihan, C Leboeuf, D Hamdan, JP Feugeas, T Tran, C Monnot, ... The Breast 44, S25, 2019 | 1 | 2019 |
| Génomique du cancer du sein appliquée aux traitements D Hamdan, TT Nguyen, M El Bouchtaoui, A Janin, G Bousquet Revue Francophone des Laboratoires 2018 (506), 52-60, 2018 | 1 | 2018 |
| A novel way to manage trastuzumab cardiotoxicity D Hamdan, F Darrouzain, T Bejan-Angoulvant, C Isorni, L Zelek, ... Cancer Chemotherapy and Pharmacology 81, 791-796, 2018 | 1 | 2018 |
| Critères d’évaluation de la TEP au 18F-FDG au cours de l’immunothérapie D Hamdan, E Anjorand, G Bousquet, M Soussan Médecine Nucléaire 48 (6), 279-286, 2024 | | 2024 |
| A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53 D Hamdan, C Gardair, F Pamoukdjian, MN Peraldi Gardin, I Nakouri, ... International Journal of Molecular Sciences 25 (2), 1147, 2024 | | 2024 |
| The germline genetics of mild-to-moderate penetrance: An intriguing role of PRAME in multiple carcinogenesis D Hamdan, J Paris, C Leboeuf, M El Bouchtaoui, M Espié, A Janin, ... Genes & Diseases 11 (3), 101003, 2023 | | 2023 |
| Pyrogenic lower limbs E Angeli, AAP González, D Hamdan, G Pop, G Falgarone, G Bousquet Annals of the Rheumatic Diseases 82 (5), 719-720, 2023 | | 2023 |
Guilhem BousquetUniversité Sorbonne Paris Nord/Inserm UMRS_942Zweryfikowany adres z aphp.fr
